Sdz 223228
| Code | Size | Price |
|---|
| TAR-T34593-5mg | 5mg | £850.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Documents
Further Information
Bioactivity:
Sdz 223228 is a bioactive chemical.
CAS:
178181-50-5
Formula:
C52H69FN10O11S2
Molecular Weight:
1093.3
Purity:
0.98
SMILES:
C[C@H](O)[C@@H](CO)NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](C)F)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N[C@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1
References
Guhlke S, Wester HJ, Bruns C, St?cklin G. (2-[18F]fluoropropionyl-(D)phe1)-octreotide, a potential radiopharmaceutical for quantitative somatostatin receptor imaging with PET: synthesis, radiolabeling, in vitro validation and biodistribution in mice. Nucl Med Biol. 1994 Aug;21(6):819-25. PubMed PMID: 9234331.
Wester HJ, Schottelius M, Scheidhauer K, Meisetschl?ger G, Herz M, Rau FC, Reubi JC, Schwaiger M. PET imaging of somatostatin receptors: design, synthesis and preclinical evaluation of a novel 18F-labelled, carbohydrated analogue of octreotide. Eur J Nucl Med Mol Imaging. 2003 Jan;30(1):117-22. Epub 2002 Nov 5. PubMed PMID: 12483418.